Status:
RECRUITING
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Gestational Diabetes
Hyperglycemia
Eligibility:
FEMALE
18-50 years
Brief Summary
One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors ...
Detailed Description
Gestational diabetes (GDM) is associated with a significantly increased risk of type 2 diabetes, with 1/3 of individuals with GDM developing glucose intolerance in the first 3 years postpartum. The Am...
Eligibility Criteria
Inclusion
- Women with a viable singleton intrauterine pregnancy
- Able to understand the study, and having understood, provide written informed consent in English
- Recent pregnancy affected by gestational diabetes
Exclusion
- Pregestational Diabetes (Type I or Type II)
- Continued use of diabetes medications (including metformin and insulin) immediately after delivery
- Preterm delivery (\< 37 weeks gestation)
- Twin or higher order gestation
- No access to a smartphone
- Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic
- Participation in this trial in a prior pregnancy
- History of skin allergy to adhesive products or CGM
Key Trial Info
Start Date :
June 6 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06184373
Start Date
June 6 2025
End Date
May 30 2027
Last Update
October 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Medical Center
Columbus, Ohio, United States, 43210